Once-Weekly Oral Combo for HIV Maintains High Rates of Virologic Suppression
08/05/2026
Estudio de combinación semanal A once-weekly oral combination of islatravir plus lenacapavir (Sunlenca) for HIV maintained similarly high rates of
La actriz ganadora de un Emmy, Christina Applegate, reveló recientemente que su diagnóstico de esclerosis múltiple (EM), que anunció por…
Read more →
Estudio de combinación semanal A once-weekly oral combination of islatravir plus lenacapavir (Sunlenca) for HIV maintained similarly high rates of
Suppressing a sneeze may have led to a spontaneous leak of cerebrospinal fluid (CSF) and air entering the skull of
NfL and Cognition Neurofilament light chain (NfL), a measure of neuronal injury, emerged as a key blood-based biomarker associated with
Introducción The interleukin-6 (IL-6) inhibitor satralizumab (Enspryng) met its primary endpoint in the phase III METEOROID trial of myelin oligodendrocyte